Skip to main navigation Skip to search Skip to main content

A Systematic Review of Clinical Practice Guidelines for Managing Pulmonary Toxicities Caused by Immune Checkpoint Inhibitors: Quality of Treatment Recommendations and Differences in Management Strategies Between Guidelines

    Research output: Contribution to journalReview articlepeer-review

    Original languageEnglish
    JournalClinical Medicine Insights: Oncology
    Volume17
    DOIs
    StatePublished - Jan 1 2023

    ASJC Scopus Subject Areas

    • Oncology

    Keywords

    • AGREE II
    • AGREE-REX
    • clinical practice guideline
    • immune-checkpoint inhibitor
    • immune-related adverse event
    • immunotherapy-related toxicity
    • lung toxicity
    • pneumonitis
    • pulmonary toxicity
    • systematic review

    Cite this